Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.
about
Use of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in miceTherapeutic and prevention strategies against human enterovirus 71 infectionLive-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent DeliveryLong-term immunological memory induced by recombinant oral Salmonella vaccine vectors.Development of mucosal protection against the heat-stable enterotoxin (ST) of Escherichia coli by oral immunization with a genetic fusion delivered by a bacterial vector.Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters.Fine-tuning synthesis of Yersinia pestis LcrV from runaway-like replication balanced-lethal plasmid in a Salmonella enterica serovar typhimurium vaccine induces protection against a lethal Y. pestis challenge in micePrior immunity to homologous and heterologous Salmonella serotypes suppresses local and systemic anti-fragment C antibody responses and protection from tetanus toxin in mice immunized with Salmonella strains expressing fragment CAttenuation and immunogenicity of Deltacya Deltacrp derivatives of Salmonella choleraesuis in pigsExpression and immunogenicity of hemagglutinin A from Porphyromonas gingivalis in an avirulent Salmonella enterica serovar typhimurium vaccine strain.Effect of preexisting immunity to Salmonella on the immune response to recombinant Salmonella enterica serovar typhimurium expressing a Porphyromonas gingivalis hemagglutinin.The response regulator PhoP is important for survival under conditions of macrophage-induced stress and virulence in Yersinia pestis.Evaluation of the humoral immune response in mice orally vaccinated with live recombinant attenuated Salmonella enterica delivering a secreted form of Yersinia pestis PsaA.Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonizationImpact of vector priming on the immunogenicity of recombinant Salmonella vaccinesProtective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine.Salmonella synthesizing 1-dephosphorylated [corrected] lipopolysaccharide exhibits low endotoxic activity while retaining its immunogenicity.Live bacterial vaccine vectors: an overview.Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium.Use of EnsureĀ® nutrition shakes as an alternative formulation method for live recombinant Attenuated Salmonella Typhi vaccines.Immunization with live recombinant Salmonella typhimurium aroA producing F1 antigen protects against plague.In vivo induction of interleukin-12 mRNA expression after oral immunization with Salmonella dublin or the B subunit of Escherichia coli heat-labile enterotoxin.Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: dose response and induction of protective humoral responses in ratsDifferential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c miceDevelopment of Shigella sonnei live oral vaccines based on defined rfbInaba deletion mutants of Vibrio cholerae expressing the Shigella serotype D O polysaccharide.Differential production of interleukin-12 mRNA by murine macrophages in response to viable or killed Salmonella spp.Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague.Oral immunization of mice with attenuated Salmonella typhimurium aroA expressing a recombinant Mycoplasma hyopneumoniae antigen (NrdF).Characterization and immunogenicity of Salmonella typhimurium SL1344 and UK-1 delta crp and delta cdt deletion mutantsOral Delivery of a Novel Attenuated Salmonella Vaccine Expressing Influenza A Virus Proteins Protects Mice against H5N1 and H1N1 Viral InfectionLive attenuated Salmonella vaccines against Mycobacterium tuberculosis with antigen delivery via the type III secretion system.Live attenuated Salmonella vaccines displaying regulated delayed lysis and delayed antigen synthesis to confer protection against Mycobacterium tuberculosis.Immunization with live aroA recombinant Salmonella typhimurium producing invasin inhibits intestinal translocation of Yersinia pseudotuberculosisA comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen.Peyer's patches are required for intestinal immunoglobulin A responses to Salmonella spp.Immunization with non-replicating E. coli minicells delivering both protein antigen and DNA protects mice from lethal challenge with lymphocytic choriomeningitis virusRegulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment.Display of heterologous proteins on the surface of microorganisms: from the screening of combinatorial libraries to live recombinant vaccines.Prophylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virusInduction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis.
P2860
Q24806827-61BEA748-9F4A-4B5E-A5B5-7ECE0A86A0B5Q28080796-190E1C6F-D3F6-410D-95FD-EC27DB472CE1Q28084076-C43B9193-8C66-4295-83F3-0CDB453A4B18Q33599589-AAA4D520-1333-4A9E-A836-FF7767806149Q33613680-8DFCDECF-03AC-4F1B-9B9A-755DEA8B3F8BQ33755979-D0AA6738-4F09-431F-8898-A4ED237B6D1BQ33877252-2526B5CB-92DB-4F77-A9C3-341EF5C370E9Q34001326-5FBE3D1A-6EEE-43C0-A52A-4ACA0B82C08FQ34001774-0ECFEC19-8298-41DB-86D4-42CB38E1E077Q34003274-B3BD322D-3EE1-44CC-8874-785F3A75601CQ34004542-560141E2-D068-40CC-A41C-EE7BDF353E43Q34004738-345C5E4F-6302-40CA-B19E-49010E153091Q34065115-B7E838B6-151F-4C84-B591-FE000000D6EDQ34083154-F21230B4-553A-4548-81E4-3889E46EBAF1Q34531946-BFB40DB6-9E60-4099-BCA4-2C97CAA084B4Q34975686-BCFB37D9-4017-40FE-959C-AB952AC2FE31Q35059006-4E12CE9D-4AE0-490A-BA37-BD2B9CBC65F3Q35068970-D9732E8E-CED3-450B-A61E-1480F7B62F25Q35273125-FB089E65-E787-4F74-BDAC-BC77FE3F9193Q35338804-6AABF65A-378E-48DA-9EB4-7F2C2EFEA4FDQ35385770-1978272A-33F1-41B2-8C32-BAF374F7E86DQ35395310-F2139AF5-1D34-40D6-9C2D-06D1BDEB59EBQ35413101-DA5B56B0-7F66-46A4-BB90-5E3DA9432243Q35452874-301FF87A-85A4-44EC-9FAD-924B9614ED15Q35469131-DA7D8053-11D1-42E9-9C52-689AFCBC73F7Q35479916-AF6CFD18-54D0-4FD8-BF32-875CDC317063Q35547366-D5726F35-938E-463B-947B-3DBF65B2BEB1Q35550140-5FFF581C-A5A2-48CF-B63E-515AD6E20778Q35561471-47F8EE6F-1A54-47C7-A533-5BA6D245CC73Q35666065-3E1A2F54-5F58-471C-A8F0-79F2EC016BDAQ35689514-1F28DAAF-5CF3-4C6E-8A3C-31E69C9FACF4Q35689518-B006A033-E916-4BCE-A8C1-6B512885C558Q35774822-E8447916-4254-4B0B-AE04-286A83398EA1Q36237899-94C34C66-DE5B-4689-878F-2DFA0E911FA3Q36483628-9B49E217-EF54-4AC1-9F35-74C35FE24D50Q36658309-621AB011-9C86-4E10-9BD5-27215BF9237BQ36756869-BDD7A2BD-433D-421F-829D-3B9B7CD4807DQ36846784-B88E1887-1BCF-4B37-8F63-9B382E4887F3Q36879345-222C8504-C42B-479D-A1BF-F46F734193B8Q37451865-05E5853E-19E1-4902-B254-1F84F5F536FE
P2860
Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.
description
1992 nĆ® lÅ«n-bĆ»n
@nan
1992幓ć®č«ę
@ja
1992幓č«ę
@yue
1992幓č«ę
@zh-hant
1992幓č«ę
@zh-hk
1992幓č«ę
@zh-mo
1992幓č«ę
@zh-tw
1992幓č®ŗę
@wuu
1992幓č®ŗę
@zh
1992幓č®ŗę
@zh-cn
name
Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.
@ast
Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.
@en
type
label
Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.
@ast
Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.
@en
prefLabel
Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.
@ast
Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.
@en
P2860
P356
P1476
Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.
@en
P2093
Clements JD
CƔrdenas L
P2860
P304
P356
10.1128/CMR.5.3.328
P407
P577
1992-07-01T00:00:00Z